Discovery Chemistry, Hoffmann-La Roche, pRED, Pharma Research & Early Development, 340 Kingsland Street, Nutley, NJ 07110, USA.
Bioorg Med Chem Lett. 2013 May 1;23(9):2793-800. doi: 10.1016/j.bmcl.2013.02.012. Epub 2013 Feb 13.
Using a structure based design approach we have identified a series of indazole substituted pyrrolopyrazines, which are potent inhibitors of JAK3. Intramolecular electronic repulsion was used as a strategy to induce a strong conformational bias within the ligand. Compounds bearing this conformation participated in a favorable hydrophobic interaction with a cysteine residue in the JAK3 binding pocket, which imparted high selectivity versus the kinome and improved selectivity within the JAK family.
我们采用基于结构的设计方法,鉴定了一系列吲唑取代的吡咯并吡嗪类化合物,它们是强效 JAK3 抑制剂。我们采用分子内电子排斥策略,在配体中诱导强烈的构象偏向。具有这种构象的化合物与 JAK3 结合口袋中的半胱氨酸残基发生有利的疏水相互作用,从而赋予其对激酶组的高选择性,并提高 JAK 家族内的选择性。